BSEGeneral6 Oct 2026 · 6 Oct 2026, 06:42 pm
Allotment of Shares pursuant to conversion of Warrants
Shukra Pharmaceuticals Ltd · 524632
✦ AI SummaryFundraise
Shukra Pharmaceuticals Ltd has allotted 17,35,000 fully paid-up equity shares to its promoters upon conversion of warrants, increasing the company's paid-up equity capital.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Allotment Of Shares Pursuant To Conversion Of Warrants
Attachments (1)
📄pdf
Download →
64175cca-22ab-40c6-acf4-ba89b6af02ae.pdf
View document text
06th October, 2026
The Listing Compliance Department The Listing Department
BSE Limited National Stock Exchange of India
P. J. Towers, Dalal Street Limited
Mumbai — 400001 Exchange Plaza, C-1, Block G
Scrip Code: 524632 Bandra Kurla Complex, Bandra (East)
Mumbai — 400051
Symbol: SHUKRAPHAR
Dear Sir/Madam,
Sub.: Outcome of Board Meeting dated October 06, 2026 - Allotment of 17,35,000
fully paid-up Equity Shares of Rupee 1/- each upon conversion of warrants into
Equity shares, on Preferential Basis
Ref: Intimation under Regulation 30 of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI
Listing Regulations")
In furtherance to our letter dated January 28, 2026, and pursuant to Regulation 30 read
with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”), we hereby inform you that the Board of
Directors of the company in its Meeting held today i.e. Tuesday, October 06, 2026, has
approved allotment of 17,35,000 fully paid up equity shares of the face value of Re.1/-
each to Ms. Anar Jayesh Patel and Anar Projects Private Limited, warrant holders
(Promoters), pursuant to exercise of their right to convert share warrants (the
“Warrants”) into equity shares and the details of the said warrants are given below:
Sr. | Namof tehe | Category | No. of |No. of | No. of | No. of
No. | Allottee (Promoter/ | warrants | warrants | warrants warrants
Non - allotted | already applied Pending
Promoter) converted | for for
conversion | conversion
1 | Ms. Anar | Promoter- | 5,00,000 |0 5,00,000 0
Jayesh Patel | Individual
2 | Anar Promoter |12,35,000 | 0 12,35,000 0
Projects Group,
Private Body
Limited Corporate
CIN : L24231GJ1993PLC019079
Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054.
Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317
17,35,000
The allotment has been made for cash, upon receipt of the remaining exercise price of
Rs.26.67/- per share warrant (being an amount equivalent to 75% of the warrant
exercise price of Rs.35.56/ - per warrant), aggregating to Rs.4,62,72,450/ - (Rupees Four
Crore Sixty-Two Lakh Seventy-Two Thousand Four Hundred Fifty Only).
The equity shares so allotted on the exercise of warrants on a preferential basis shall
rank pari passu with the existing equity shares of the Company in all respects.
Consequent to the aforesaid allotment, the paid-up equity capital of the Company has
increased from Rs.44,07,87,440/- consisting of 44,07,87,440 Equity Shares of Re.1/-
each to Rs.44,25,22,440/ - consisting of 44,25,22,440 Equity Shares of Re.1/- each.
After considering the aforementioned allotment of 17,35,000 equity shares pursuant
to the conversion of fully convertible warrants, the reconciliation of outstanding
warrants as allotted on January 28, 2026, would remain as below:
Particulars No. of Warrants
Total Warrants allotted on January 28, 2026 46,43,000
Less: Warrants converted into equity shares till October 06, 46,43,000
2026
Total Outstanding Warrants 0
It may be please noted that no warrants are outstanding for conversion as on now.
Details as required under SEBI Circular No. HO/49/14/14(7)2025-CFD-
POD2/1/3762/2026 dated 30t January, 2026, is enclosed herewith as Annexure A.
The Board Meeting commenced at 06:00 p.m. and concluded at 06:30 p.m.
Kindly take the same on your records.
Thanking you,
Yours faithfully,
For Shukra Pharmaceuticals Limited
Shivkant Dhakad
Company Secretary
Mem No : A80894
CIN : L24231GJ1993PLC019079
Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054.
Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317
PHARMACEUTICAL
"""" Annexure- A"
SN | Particulars Details
1 | Types of Securities Equity Shares are allotted on the conversion of fully paid Warrants.
proposed to be issued
2 | Types of Issuances Preferential allotment on a private placement basis in accordance
with the provisions of the Companies Act, 2013 and the rules made
thereunder and SEBI (Issue of Capital and Disclosure Requirements)
Regulations, 2018, as amended (“ICDR Regulations”) and other
applicable laws.
(Conversion of Warrants into Equity Shares).
3 | Total number of securities | Allotment of 17,35,000 (Seventeen Lakhs Thirty-Five Thousand)
proposed to be issued or | Equity Shares of the face value of Re.1/- each upon conversion of
the total amount for which | equal number of warrants at an issue price of Rs.35.56/- each
the securities will be issued | (Thirty-Five Rupees and Fifty Six Paisa Only) upon receipt of the
(Approximately) balance amount at the rate of Rs.26.67/- (Twenty Six Rupees Sixty
Seven Paisa Only) per warrant (as “Warrant Exercise Price”)
aggregating to Rs.4,62,72,450/ - (Rupees Four Crore Sixty-Two Lakh
Seventy-Two Thousand Four Hundred Fifty Only).
4 | Name of the Investors As per Schedule -1
5 | Post allotment of The equity shares are proposed to be allotted to Promoters. Details
securities- outcome of the | of the shareholding of Investors in the Company, prior to and after
subscription the proposed Preferential Issue, are as under:
As per Schedule - 1
6 | Issue Price Warrants had been allotted on January 28, 2026, carrying a right to
subscribe to 1 Equity Share per warrant on receipt of the amount at
Rs.8.89/- per warrant (25% of the issue price per warrant).
Now, 17,35,000 Equity Shares have been allotted on receipt of
balance amount at the rate of Rs.26.67/- per warrant (being 75% of
the issue price per warrant) on October 06, 2026.
7 | Number of Investors 2
8 | In case of convertibles — | Not Applicable
Intimation on conversion
of securities or on lapse of
the tenure of the
instrument;
9 |Any cancellation or | Not Applicable
termination of proposal
for issuance of securities
including reasons thereof.
CIN : L24231GJ1993PLC019079
Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054.
Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317
HARMACEUTICALS LTD:
Schedule - I
Sr. | Name of | Pre issue shareholding | Postissue shareholding
No. | Shareholder No. of Percentage No. of Percentage
equity shares Post of total
shares held capital holding
(post
diluted)
1 |[Ms. Anar| 43,60,000 0.99 48,60,000 1.10
Jayesh Patel
2 | Anar 8,22,40,000 18.71 8,34,75,000 18.91
Projects
Private
Limited
Total 8,66,00,000 19.70 8,83,35,000 20.01
CIN : L24231GJ1993PLC019079
Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054.
Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317